Alison Meagher

2.0k total citations
23 papers, 1.6k citations indexed

About

Alison Meagher is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Alison Meagher has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 11 papers in Molecular Medicine and 7 papers in Infectious Diseases. Recurrent topics in Alison Meagher's work include Antibiotics Pharmacokinetics and Efficacy (15 papers), Antibiotic Resistance in Bacteria (11 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Alison Meagher is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (15 papers), Antibiotic Resistance in Bacteria (11 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Alison Meagher collaborates with scholars based in United States, Australia and Germany. Alison Meagher's co-authors include Jerome J. Schentag, Craig R. Rayner, Mary C. Birmingham, Alan Forrest, Evelyn J. Ellis‐Grosse, Paul G. Ambrose, Thaddeus H. Grasela, Donald H. Batts, Scott A. Van Wart and Brenda Cirincione and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Alison Meagher

23 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Meagher United States 16 1.0k 799 709 475 471 23 1.6k
J. Blaser Switzerland 21 995 1.0× 363 0.5× 654 0.9× 544 1.1× 271 0.6× 51 1.6k
Elizabeth Neuner United States 20 517 0.5× 345 0.4× 793 1.1× 612 1.3× 365 0.8× 53 1.4k
Marie-Dominique Kitzis France 19 683 0.7× 411 0.5× 799 1.1× 523 1.1× 198 0.4× 48 1.5k
Evan J Zasowski United States 19 726 0.7× 883 1.1× 463 0.7× 468 1.0× 632 1.3× 49 1.6k
Ómar Vesga Colombia 17 529 0.5× 432 0.5× 356 0.5× 272 0.6× 176 0.4× 34 1.3k
Christina Sutherland United States 21 712 0.7× 217 0.3× 577 0.8× 373 0.8× 227 0.5× 45 1.1k
Giusy Tiseo Italy 22 539 0.5× 382 0.5× 890 1.3× 533 1.1× 213 0.5× 62 1.6k
Εlias Iosifidis Greece 23 459 0.5× 382 0.5× 792 1.1× 670 1.4× 188 0.4× 82 1.5k
Katie E. Barber United States 21 405 0.4× 827 1.0× 371 0.5× 471 1.0× 421 0.9× 89 1.5k
Jared L. Crandon United States 30 1.4k 1.3× 392 0.5× 1.3k 1.9× 734 1.5× 235 0.5× 63 2.1k

Countries citing papers authored by Alison Meagher

Since Specialization
Citations

This map shows the geographic impact of Alison Meagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Meagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Meagher more than expected).

Fields of papers citing papers by Alison Meagher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Meagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Meagher. The network helps show where Alison Meagher may publish in the future.

Co-authorship network of co-authors of Alison Meagher

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Meagher. A scholar is included among the top collaborators of Alison Meagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Meagher. Alison Meagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Kwon, Jennifer M. & Alison Meagher. (2012). Crizotinib: A Breakthrough for Targeted Therapies in Lung Cance. Journal of the Advanced Practitioner in Oncology. 3(4). 267–72. 3 indexed citations
4.
Dhillon, Samjot S., Alison Meagher, Todd L. Demmy, Graham Warren, & Sai Yendamuri. (2012). Metformin Usage and Not Diabetes Influences the Long Term Survival of Resected Early Stage Non-small Cell Lung Cancer Patients. CHEST Journal. 142(4). 622A–622A. 1 indexed citations
5.
Ambrose, Paul G., Alison Meagher, Julie Passarell, et al.. (2009). Application of patient population-derived pharmacokinetic–pharmacodynamic relationships to tigecycline breakpoint determination for staphylococci and streptococci. Diagnostic Microbiology and Infectious Disease. 63(2). 155–159. 17 indexed citations
6.
Passarell, Julie, Elizabeth Ludwig, Alison Meagher, et al.. (2009). Exposure–response analyses of tigecycline tolerability in healthy subjects. Diagnostic Microbiology and Infectious Disease. 65(2). 123–129. 12 indexed citations
7.
Ambrose, Paul G., Alison Meagher, Julie Passarell, et al.. (2008). Use of a clinically derived exposure–response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints. Diagnostic Microbiology and Infectious Disease. 63(1). 38–42. 13 indexed citations
8.
Wart, Scott A. Van, et al.. (2007). Population Pharmacokinetics of Tigecycline in Healthy Volunteers. The Journal of Clinical Pharmacology. 47(6). 727–737. 26 indexed citations
9.
Passarell, Julie, Alison Meagher, Brenda Cirincione, et al.. (2007). Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Intra-Abdominal Infections. Antimicrobial Agents and Chemotherapy. 52(1). 204–210. 84 indexed citations
10.
Meagher, Alison, Julie Passarell, Brenda Cirincione, et al.. (2007). Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Skin and Skin-Structure Infections. Antimicrobial Agents and Chemotherapy. 51(6). 1939–1945. 90 indexed citations
11.
Meagher, Alison, Paul G. Ambrose, Thaddeus H. Grasela, & Evelyn J. Ellis‐Grosse. (2005). Pharmacokinetic/pharmacodynamic profile for tigecycline—a new glycylcycline antimicrobial agent. Diagnostic Microbiology and Infectious Disease. 52(3). 165–171. 102 indexed citations
12.
Meagher, Alison, Paul G. Ambrose, Thaddeus H. Grasela, & Evelyn J. Ellis‐Grosse. (2005). The Pharmacokinetic and Pharmacodynamic Profile of Tigecycline. Clinical Infectious Diseases. 41(s5). S333–S340. 155 indexed citations
13.
Rayner, Craig R., Larry M. Baddour, Mary C. Birmingham, et al.. (2004). Linezolid in the Treatment of Osteomyelitis: Results of Compassionate Use Experience. Infection. 32(1). 8–14. 97 indexed citations
14.
Meagher, Alison, Alan Forrest, A. Dalhoff, Heino Staß, & Jerome J. Schentag. (2004). Novel Pharmacokinetic-Pharmacodynamic Model forPrediction of Outcomes with an Extended-Release FormulationofCiprofloxacin. Antimicrobial Agents and Chemotherapy. 48(6). 2061–2068. 62 indexed citations
15.
Smith, Patrick F., Mary C. Birmingham, Gary A. Noskin, et al.. (2003). Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia. Annals of Oncology. 14(5). 795–801. 56 indexed citations
16.
Rayner, Craig R., Alan Forrest, Alison Meagher, Mary C. Birmingham, & Jerome J. Schentag. (2003). Clinical Pharmacodynamics of Linezolid in Seriously Ill Patients Treated in a Compassionate Use Programme. Clinical Pharmacokinetics. 42(15). 1411–1423. 244 indexed citations
17.
Birmingham, Mary C., et al.. (2003). Linezolid for the Treatment of Multidrug‐Resistant, Gram‐Positive Infections: Experience from a Compassionate‐Use Program. Clinical Infectious Diseases. 36(2). 159–168. 324 indexed citations
18.
Meagher, Alison, Alan Forrest, Craig R. Rayner, Mary C. Birmingham, & Jerome J. Schentag. (2003). Population Pharmacokinetics of Linezolid in Patients Treated in a Compassionate-Use Program. Antimicrobial Agents and Chemotherapy. 47(2). 548–553. 129 indexed citations
19.
Schentag, Jerome J., Alison Meagher, & Alan Forrest. (2003). Fluoroquinolone AUIC Break Points and the Link to Bacterial Killing Rates Part 2: Human Trials. Annals of Pharmacotherapy. 37(10). 1478–1488. 69 indexed citations
20.
Zuckerman, Jonathan B., et al.. (2002). Successful treatment of methicillin‐resistant Staphylococcus aureus pulmonary infection with linezolid in a patient with cystic fibrosis. Pediatric Pulmonology. 33(3). 221–223. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Blaser Breakdown of academic impact, for papers by Elizabeth Neuner Breakdown of academic impact, for papers by Marie-Dominique Kitzis Breakdown of academic impact, for papers by Evan J Zasowski Breakdown of academic impact, for papers by Ómar Vesga Breakdown of academic impact, for papers by Christina Sutherland Breakdown of academic impact, for papers by Giusy Tiseo Breakdown of academic impact, for papers by Εlias Iosifidis Breakdown of academic impact, for papers by Katie E. Barber Breakdown of academic impact, for papers by Jared L. Crandon
Rankless by CCL
2026